Found: 7
Select item for more details and to access through your institution.
Author Correction: CD98hc is a target for brain delivery of biotherapeutics.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41355-x
- By:
- Publication type:
- Article
CD98hc is a target for brain delivery of biotherapeutics.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40681-4
- By:
- Publication type:
- Article
Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogates.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 3, p. 601, doi. 10.1007/s11060-022-04179-1
- By:
- Publication type:
- Article
Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and <sup>18</sup>F-FDG/PET.
- Published in:
- Magnetic Resonance in Medicine, 2013, v. 69, n. 3, p. 781, doi. 10.1002/mrm.24318
- By:
- Publication type:
- Article
Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and <sup>18</sup>F-FDG/PET.
- Published in:
- Magnetic Resonance in Medicine, 2015, v. 73, n. 2, p. 740, doi. 10.1002/mrm.25151
- By:
- Publication type:
- Article
Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy.
- Published in:
- AAPS Journal, 2008, v. 10, n. 1, p. 166, doi. 10.1208/s12248-008-9018-7
- By:
- Publication type:
- Article
Impact of drug size on brain tumor and brain parenchyma delivery after a blood-brain barrier disruption.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2014, v. 34, n. 5, p. 820, doi. 10.1038/jcbfm.2014.14
- By:
- Publication type:
- Article